CHICAGO – Improved radiotherapy techniques have made it possible for men to achieve reductions in PSA to below detectable levels following radiation treatment for prostate cancer, according to new ...
Among men with PSA persistence after radical prostatectomy, a higher preoperative PSA surprisingly was linked to lower mortality. Men with PSA persistence and preoperative PSA >20 ng/mL had 31% lower ...
Investigators evaluated the benefit of leuprorelin immediately after radical prostatectomy for prostate cancer in patients ...
Adjuvant Therapy With Pegylated Interferon Alfa-2b Versus Observation in Resected Stage III Melanoma: A Phase III Randomized Controlled Trial of Health-Related Quality of Life and Symptoms by the ...
SYDNEY, Nov. 30, 2023 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity", "the Company"), a clinical stage radiopharmaceutical company with a mission to develop next-generation products ...
We report the development of a previously undescribed gold nanoparticle bio-barcode assay probe for the detection of prostate specific antigen (PSA) at 330 fg/mL, automation of the assay, and the ...
In real-world practice, the faster and deeper the PSA response to apalutamide plus ADT in men with mHSPC, the better the survival rate. Overall survival rates are higher for men experiencing deep and ...
Forty-eight patients with metastatic HRPC were registered. Forty-two patients were eligible, with a median age of 73 years and a median PSA level of 111 ng/mL; 78% had bone-only or bone and soft ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results